Jiang Li-Qin, Chen Shan-Jiang, Xu Jian-Jiang, Ran Zhang, Ying Wang, Zhao Sheng-Gang
Cell Physiol Biochem. 2016;38(6):2311-22. doi: 10.1159/000445585. Epub 2016 May 23.
BACKGROUND/AIMS: Amiodarone, a thyroid hormone-like molecule, can induce dyslipidemia and thyroid dysfunction. However, the effects of dronedarone on lipid metabolism and of both dronedarone and amiodarone on thyroid function and lipid metabolism remain unknown.
Fifty male Sprague-Dawley rats were randomly divided into 5 groups (10 in each group): normal control (NC), amiodarone-treated (AMT), dronedarone-treated (DRT), rats treated with amiodarone combined with polyene phosphatidylcholine (AC), and rats treated with dronedarone combined with polyene phosphatidylcholine (DC). Rats were given amiodarone (120 mg/kg/d), dronedarone (120 mg/kg/d), and polyene phosphatidylcholine (200 mg/kg/d) for 13 weeks. At the end of weeks 4, 8, 12, and 13, plasma-free triiodothyronine (FT3), free thyroxine (FT4), triglycerides (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), and high-density lipoprotein cholesterol (HDL-c) were determined. At the end of this protocol, rats were sacrificed and the thyroid glands were isolated, weighed, and examined histopathologically. The protein expression of Bcl-2 was measured by immunochemical staining. The mRNA expression of thyroglobulin (Tg), type-1 deiodinase (D1), and thyroid peroxidase (TPO) were detected by polymerase chain reaction (PCR).
Compared with the NC group, FT3 and FT4 levels in the DRT and DC groups significantly increased at week 4 but declined thereafter. The AMT and AC groups had lower FT3 levels but comparable FT4 levels. The levels of TG, LDL-c, and HDL-c in the NC group were lower than those in the other groups whereas the LDL-c/HDL-c ratio was lowest in the AMT group. Bcl-2 expression significantly increased in the DRT group. The mRNA expression of Tg increased whereas the mRNA expression of D1 decreased. Dronedarone induced hyperthyroidism at the early stage and hypothyroidism at the late stage whereas amiodarone only caused hypothyroidism.
Both dronedarone and amiodarone can induce dyslipidemia and increase the levels of TC, LDL-c, and HDL-c, and these effects may be associated with thyroid dysfunction.
背景/目的:胺碘酮是一种类似甲状腺激素的分子,可诱发血脂异常和甲状腺功能障碍。然而,决奈达隆对脂质代谢的影响以及决奈达隆和胺碘酮对甲状腺功能及脂质代谢的影响尚不清楚。
将50只雄性Sprague-Dawley大鼠随机分为5组(每组10只):正常对照组(NC)、胺碘酮治疗组(AMT)、决奈达隆治疗组(DRT)、胺碘酮联合多烯磷脂酰胆碱治疗组(AC)和决奈达隆联合多烯磷脂酰胆碱治疗组(DC)。大鼠分别给予胺碘酮(120mg/kg/d)、决奈达隆(120mg/kg/d)和多烯磷脂酰胆碱(200mg/kg/d),持续13周。在第4、8、12和13周结束时,测定血浆游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-c)和高密度脂蛋白胆固醇(HDL-c)。在该实验方案结束时,处死大鼠,分离甲状腺,称重并进行组织病理学检查。通过免疫化学染色测定Bcl-2的蛋白表达。通过聚合酶链反应(PCR)检测甲状腺球蛋白(Tg)、1型脱碘酶(D1)和甲状腺过氧化物酶(TPO)的mRNA表达。
与NC组相比,DRT组和DC组的FT3和FT4水平在第4周时显著升高,但随后下降。AMT组和AC组的FT3水平较低,但FT4水平相当。NC组的TG、LDL-c和HDL-c水平低于其他组,而AMT组的LDL-c/HDL-c比值最低。DRT组中Bcl-2表达显著增加。Tg的mRNA表达增加,而D1的mRNA表达降低。决奈达隆在早期诱发甲状腺功能亢进,在后期诱发甲状腺功能减退,而胺碘酮仅导致甲状腺功能减退。
决奈达隆和胺碘酮均可诱发血脂异常,并使TC/LDL-c和HDL-c水平升高,这些影响可能与甲状腺功能障碍有关。